GLAM
AVNR

Gardner Lewis Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Gardner Lewis Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-716,994
Closed -$12.2M – 117
2014
Q4 		$12.2M Buy
+716,994
New +$10.1M 2.45% 9

Gardner Lewis Asset Management's AVNR Position: Q1 2015 in Review

Gardner Lewis Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 716,994 shares — an estimated $12.2M sold.

Gardner Lewis Asset Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $12.2M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Gardner Lewis Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 716,994 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $12.2M.
  • Gardner Lewis Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Gardner Lewis Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $12.2M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2015, filed 14 May 2015.